Posted on January 7, 2013 by Sitemaster
In yet another utterly unsurprising “research” finding, a new article in the Journal of Urology has shown that — in the USA — minority prostate cancer patients and prostate cancer patients treated under Medicaid are less likely to have their prostates removed at high-experience and high-volume hospitals where there is high use of robot-assisted surgical techniques. … READ MORE …
Filed under: Diagnosis, Living with Prostate Cancer, Management, Risk, Treatment | Tagged: access, Medicaid, minority, outcome, quality, surgery, volume | 5 Comments »
Posted on July 7, 2011 by Sitemaster
The “New” Prostate Cancer InfoLink is delighted to see the early results of a major study conducted by the National Bureau of Economic Research which has effectively proven that patients on Medicaid find regular doctors, see those doctors more often, feel better, are less depressed, and are better able to maintain financial stability than those with no health care insurance. … READ MORE …
Filed under: Diagnosis, Living with Prostate Cancer, Management, Risk | Tagged: health care, Medicaid, quality, uninsured | 2 Comments »
Posted on July 1, 2010 by Sitemaster
Yesterday evening, the Centers for Medicare and Medicaid Services (CMS) announced that it was opening a “national coverage analysis to determine whether or not autologous cellular immunotherapy [for prostate cancer with sipuleucel-T/Provenge] is reasonable and necessary.” … READ MORE …
Filed under: Management | Tagged: coverage, Medicaid, Medicare, Provenge, sipuleucel-T | 3 Comments »
THE "NEW" PROSTATE CANCER INFOLINK 